Comparison of Cytotoxicity Evaluation of Anticancer Drugs Between Real-Time Cell Analysis and CCK-8 Method

ACS Omega - United States
doi 10.1021/acsomega.9b01142
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Chemical Society (ACS)

Related search

Comparison Between xCELLigence Biosensor Technology and Conventional Cell Culture System for Real-Time Monitoring Human Tenocytes Proliferation and Drugs Cytotoxicity Screening

Journal of Orthopaedic Surgery and Research
SurgeryOrthopedicsSports Medicine
2017English

Evaluation of Anticancer Drugs by Lymphocyte Electrophoresis.

Journal of Pharmacobio-Dynamics
1986English

A Comparison of the in Vitro Genotoxicity of Anticancer Drugs Melphalan and Mitoxantrone

American Journal of Biomedical Sciences
2013English

Metabolic Monosaccharides Altered Cell Responses to Anticancer Drugs

European Journal of Pharmaceutics and Biopharmaceutics
MedicineBiotechnologyPharmaceutical Science
2012English

Real-Time Analysis Sensitivity Evaluation of the Cherenkov Telescope Array

2016English

Lack of Correlation Between the Costs of Anticancer Drugs and Clinical Benefits in Japan

Cancer Science
Cancer ResearchMedicineOncology
2018English

Novel Method Based on Real-Time Cell Analysis for Drug Susceptibility Testing of Herpes Simplex Virus and Human Cytomegalovirus

Journal of Clinical Microbiology
Microbiology
2016English

Correlation Between Clostridium Difficile Bacterial Load, Commercial Real-Time PCR Cycle Thresholds, and Results of Diagnostic Tests Based on Enzyme Immunoassay and Cell Culture Cytotoxicity Assay

Journal of Clinical Microbiology
Microbiology
2013English

In Vitro Anticancer Activity and Cytotoxicity of Some Papaver Alkaloids on Cancer and Normal Cell Lines

African Journal of Traditional, Complementary and Alternative Medicines
MedicineDrug DiscoveryAlternative MedicineComplementary
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy